Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinolines as PDE4 inhibitorsMotasim Billah, George M Buckley, Nicola Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitorsEric J Gilbert, Guowei Zhou, Michael K C Wong, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of SCH 900188: A Potent Hepatitis C Virus NS5B Polymerase Inhibitor Prodrug As a Development CandidateKevin X Chen, Srikanth Venkatraman, Gopinadhan N Anilkumar, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2011
III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffoldSeong Heon Kim, Gopinadhan N Anilkumar, Lisa Guise Zawacki, et al.
Bioorganic & Medicinal Chemistry|February 26, 2013
Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymeraseSrikanth Venkatraman, Francisco Velazquez, Stephen Gavalas, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitorsChaoyang Dai, Dansu Li, Janeta Popovici-Muller, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Bioorganic & Medicinal Chemistry|November 27, 2013
Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokineticsSrikanth Venkatraman, Francisco Velazquez, Stephen Gavalas, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2011
II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamidesGopinadhan N Anilkumar, Oleg Selyutin, Stuart B Rosenblum, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine CoreTao Yu, Jayaram R Tagat, Angela D Kerekes, et al.
Pageof 7